An α-Gal antigenic surrogate as a biomarker of treatment evaluation in Trypanosoma cruzi-infected children. A retrospective cohort study.
<h4>Background</h4>Proper evaluation of therapeutic responses in Chagas disease is hampered by the prolonged persistence of antibodies to Trypanosoma cruzi measured by conventional serological tests and by the lack of sensitivity of parasitological tests. Previous studies indicated that...
Saved in:
Main Authors: | Manuel Abal (Author), Virginia Balouz (Author), Rosana Lopez (Author), M Eugenia Giorgi (Author), Carla Marino (Author), Cintia V Cruz (Author), Jaime Altcheh (Author), Carlos A Buscaglia (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular and antigenic characterization of Trypanosoma cruzi TolT proteins.
by: Maite Lobo, et al.
Published: (2019) -
The Trypomastigote Small Surface Antigen (TSSA) regulates Trypanosoma cruzi infectivity and differentiation.
by: María de Los Milagros Cámara, et al.
Published: (2017) -
Deep serological profiling of the Trypanosoma cruzi TSSA antigen reveals different epitopes and modes of recognition by Chagas disease patients.
by: Guadalupe Romer, et al.
Published: (2023) -
α-Gal immunization positively impacts Trypanosoma cruzi colonization of heart tissue in a mouse model.
by: Gisele Macêdo Rodrigues da Cunha, et al.
Published: (2021) -
A novel antibody surrogate biomarker to monitor parasite persistence in Trypanosoma cruzi-infected patients.
by: Maan Zrein, et al.
Published: (2018)